Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1442 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

HealthSport, Cure Pharmaceutical sign LOI

Under the non-binding LOI, the parties will contribute technology, research and development and other resources and will negotiate the formation of a joint venture, for the development and

Genzyme revenues rise in Q3

Genzyme has posted a net income of $68.95m for the third quarter 2010, or $0.26 per diluted share, compared to $16m, or $0.06 per diluted share, for the

Delcath makes key appointments in R&D

Appling and Johnston will be based in the company’s Queensbury, New York facility and report to the executive vice president of Research and Development, and Delcath’s chief medical

Meda Breakyl receives European approval

Breakyl (also known as Onsolis or BEMA Fentanyl) is indicated for the management of pain in opioid tolerant adult patients with cancer. Meda claims that Breakyl uses a

Abbott Q3 net sales up 11.8%

Abbott has posted net earnings of $891m for the third quarter 2010, or $0.57 per diluted share, compared to net earnings of $1.48bn, or $0.95 per diluted share,

Alcon Q3 sales increase

Alcon has posted a net earnings of $446m for the third quarter 2010, or $1.47 per diluted share, compared to net earnings of $515m, or $1.71 per diluted

DiaMedica names new vice president of Finance

Previously, Parsons was the chief financial officer for both private and public life science companies including Amorfix Life Sciences, Trillium Therapeutics and Lorus Therapeutics. DiaMedica president and CEO

HCPlexus partners Healthline Networks

Under the partnership, HCPlexus and Healthline Networks are expected to extend their current advertising networks, as well as the new point-of-care information platform, to provide contextual and direct